|
|
(Video is about 8 minutes)
Depression remains the leading cause of disability worldwide, affecting almost 300 million people, half of whom can't find lasting relief from drugs or therapy. But a new experimental treatment using a fast-acting approach with targeted magnetic stimulation, called SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy), has achieved significant success in trials. Correspondent Lee Cowan reports. |
(Video is about 14 minutes)
If you have severe depression, PTSD, or anxiety that just won’t go away despite therapy and medication you should know about Ketamine. 30-40% of people with depression have treatment resistant depression (that means that you’ve tried at least 2 types of medication and it isn't helping). And scientists and doctors are really excited about the potential for ketamine as a new and effective treatment for mood disorders, PTSD, and Chronic Pain. |